[1] Migliore L, Boni G, Bernardini R, Trippi F, Colognato R, Fontana I, Coppedè F, Sbrana I. Susceptibility to chromo-some malsegregation in lymphocytes of women who had a Down syndrome child in young age. Neurobiol Aging, 2006, 27(5): 710–716.

[2] James SJ, Pogribna M, Pogribny IP, Melnyk S, Hine RJ, Gibson JB, Yi P, Tafoya DL, Swenson DH, Wilson VL, Gaylor DW. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be ma-ternal risk factorsfor Down syndrome. Am J Clin Nutr, 1999, 70(4): 495–501.

[3] Hobbs CA, Sherman SL, Yi P, Hopkins SE, Torfs CP, Hine RJ, Pogribna M, Rozen R, James SJ. Polymorphisms in genes involved in folate metabolism as maternal risk fac-tors for Down syndrome. Am J Hum Genet, 2000, 67(3): 623–630.

[4] Scala I, Granese B, Sellitto M, Salome S, Sammartino A, Pepe A, Mastroiacovo P, Sebastio G, Andria G. Analysis of seven maternal polymorphisms of genes involved in ho-mocysteine/folate metabolism and risk of Down syndrome offspring. Genet Med, 2006, 8(7): 409–416.

[5] Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in me-thylenetetrahydrofolate reductase. Nat Genet, 1995, 10(1): 111–113.

[6] Chango A, Emery-Fillon N, de Courcy GP, Lambert D, Pfister M, Rosenblatt DS, Nicolas JP. A polymorphism (80G→A) in the reduced folate carrier gene and its asso-ciations with folate status and homocysteinemia. Mol Genet Metab, 2000, 70(4): 310–315.

[7] Bosco P, Gueant-Rodriguez RM, Anello G, Barone C, Namour F, Caraci F, Romano A, Romano C, Gueant JL. Methionine synthase (MTR) 2756 (A→G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am J Med Genet A, 2003, 121(3): 219–224.

[8] 史庆华, 许波, 杨庆岭, 陈大蔚, 侯贺礼, 马铁梁, 郑媛. 非整倍体和人类生殖健康. 中国科学技术大学学报, 2008, 38(8): 388–988.

[9] 郑陈光, 覃靖, 杜娟, 陈科, 陈赤, 田晓先, 相蕾, 孙亮, 杨泽. 南宁地区唐氏综合征患者的细胞遗传学研究. 遗传, 2009, 31(3): 261–264.

[10] Wang X, Thomas P, Xue J, Fenech M. Folate deficiency-induces aneuploidy in human lymphocytes in vi-tro-evidenceusing cytokinesis-blocked cells and probes specific for chromosomes 17 and 21. Mutat Res, 2004, 551(1–2): 167–180.

[11] Fenech M. The role of folic acid and Vitamin B12 in ge-nomic stability of human cells. Mutat Res, 2001, 475(1–2): 57–67.

[12] Rai AK, Singh S, Mehta S, Kumar A, Pandey LK, Raman R. MTHFR C677T and A1298C polymorphisms are risk factors for Down's syndrome in Indian mothers. J Hum Genet, 2006, 51(4): 278–283.

[13] da Silva LR, Vergani N, Galdieri Lde C, Ribeiro Porto MP, Longhitano SB, Brunoni D, D'Almeida V, Alvarez Perez AB. Relationship between polymorphisms in genes in-volved in homocysteine metabolism and maternal risk for Down syndrome in Brazil. Am J Med Genet A, 2005, 135(3): 263–267.

[14] Chango A, Fillon-Emery N, Mircher C, Blehaut H, Lam-bert D, Herbeth B, James SJ, Rethore MO, Nicolas JP. No association between common polymorphisms in genes of folate and homocysteine metabolism and the risk of Down's syndrome among French mothers. Br J Nutr, 2005, 94(2): 166–169.

[15] Takamura N, Kondoh T, Ohgi S, Arisawa K, Mine M, Ya-mashita S, Aoyagi K. Abnormal folic acid-homocysteine metabolism as maternal risk factors for Down syndrome in Japan. Eur J Nutr, 2004, 43(5): 285–287.

[16] Coppede F, Marini G, Bargagna S, Stuppia L, Minichilli F, Fontana I, Colognato R, Astrea G, Palka G, Migliore L. Folate gene polymorphisms and